Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma - Related Studies

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma

This study is ongoing, but not recruiting participants.

Study NCT00003955. Last updated on August 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Sarcoma

2	Additional conditions recognized in this trial
		Rhabdomyosarcoma

3	More general conditions related to this trial
		Myosarcoma
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Connective and Soft Tissue
		Neoplasms, Muscle Tissue

4	Interventions listed in this trial
		cyclophosphamide
		dactinomycin
		filgrastim
		irinotecan hydrochloride
		pegfilgrastim
		sargramostim
		vincristine sulfate
		radiation therapy

5	Additional drug interventions recognized in this trial
		Camptothecin
		Irinotecan
		Vincristine

6	More general drug interventions related to this trial
		Alkylating Agents
		Anti-Bacterial Agents
		Anti-Infective Agents
		Antibiotics, Antineoplastic
		Antimitotic Agents
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antineoplastic Agents, Phytogenic
		Antirheumatic Agents
		Enzyme Inhibitors
		Immunologic Factors
		Immunosuppressive Agents
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Nucleic Acid Synthesis Inhibitors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Protein Synthesis Inhibitors
		Therapeutic Uses
		Tubulin Modulators

7	Sponsors listed in this trial
		Children's Oncology Group
		National Cancer Institute (NCI)